Comparing 2 hypotheses side-by-side
## Mechanistic Overview Complement C1q Mimetic Decoy Therapy starts from the claim that modulating C1QA within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The complement component 1q (C1q) represents a critical molecular bridge between innate immunity and synaptic plasticity in the central nervous system. C1q is a hexameric glycoprotein composed of three distinct polypeptide chains (C1qA,
## Mechanistic Overview Complement C1QA Spatial Gradient in Cortical Layers starts from the claim that modulating C1QA within the disease context of Alzheimer's Disease can redirect a disease-relevant process. The original description reads: "C1QA, the initiating protein of the classical complement cascade, shows upregulation in the SEA-AD dataset with a layer-specific spatial gradient across cortical neurons in the middle temporal gyrus. This finding connects complement-mediated synaptic taggin
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | Complement C1q Mimetic Decoy T | Complement C1QA Spatial Gradie |
|---|---|---|
| Mechanistic | 0.750 | 0.650 |
| Evidence | 0.680 | 0.550 |
| Novelty | 0.820 | 0.700 |
| Feasibility | 0.620 | 0.550 |
| Impact | 0.780 | 0.600 |
| Druggability | 0.580 | 0.500 |
| Safety | 0.650 | 0.500 |
| Competition | 0.850 | 0.600 |
| Data | 0.720 | 0.600 |
| Reproducible | 0.580 | 0.550 |
| KG Connect | 0.728 | 0.728 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.95
# Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Description:** Engineer synthetic C1q mimetics that bind to sy...
# Novel Therapeutic Hypotheses for Synaptic Pruning in Early Alzheimer's Disease ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Description:** Engineer synthetic C1q mimetics that bind to sy...
# Critical Evaluation of Synaptic Pruning Therapeutic Hypotheses ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Specific Weaknesses:** - **Selectivity Problem:** C1q has essential physiolog...
# Critical Evaluation of Synaptic Pruning Therapeutic Hypotheses ## Hypothesis 1: Complement C1q Mimetic Decoy Therapy **Specific Weaknesses:** - **Selectivity Problem:** C1q has essential physiolog...
3 rounds · quality: 0.68
# Bold Mechanistic Hypotheses: Cell-Type Specific Neurodegeneration Gene Expression in SEA-AD ## Hypothesis 1: The "Selective Vulnerability through Metabolic Licensing" Model I propose that neurodeg...
# Skeptical Commentary on Cell-Type Specific Expression Patterns in SEA-AD I must press on several methodological vulnerabilities that deserve scrutiny before accepting these cell-type specific concl...
# Cell-Type Specific Expression Patterns of Neurodegeneration Genes in SEA-AD The Southeast Asian Alzheimer's Disease (SEA-AD) cohort has revealed critical cell-type specific vulnerabilities that cha...
Curated mechanism pathway diagrams from expert analysis
graph TD
subgraph Disease["Pathological State"]
A["Neurodegeneration Trigger"] -->|"upregulates"| B["C1QA Gene Expression"]
B -->|"produces"| C["C1q Hexameric Complex"]
C -->|"binds to"| D["Synaptic Eat-Me Signals"]
D -->|"includes"| E["Phosphatidylserine and Amyloid-beta"]
C -->|"activates"| F["Classical Complement Cascade"]
F -->|"generates"| G["C3 Convertase Formation"]
G -->|"produces"| H["C3b Opsonization"]
H -->|"recruits"| I["Microglial CR3 Receptors"]
I -->|"triggers"| J["Synaptic Phagocytosis"]
end
subgraph Therapy["C1q Mimetic Decoy Intervention"]
K["C1q Mimetic Decoy Molecule"] -->|"competes with"| C
K -->|"blocks"| D
L["Therapeutic Administration"] -->|"delivers"| K
M["Decoy Sequestration"] -->|"prevents"| F
end
subgraph Outcome["Clinical Endpoints"]
N["Synaptic Preservation"] -->|"maintains"| O["Cognitive Function"]
P["Reduced Neuroinflammation"] -->|"improves"| Q["Neurological Outcomes"]
R["Biomarker Monitoring"] -->|"tracks"| N
end
K -->|"reduces"| J
M -->|"leads to"| N
M -->|"results in"| P
style A fill:#ef5350,stroke:#333,color:#000
style B fill:#ce93d8,stroke:#333,color:#000
style C fill:#ef5350,stroke:#333,color:#000
style D fill:#ef5350,stroke:#333,color:#000
style E fill:#ef5350,stroke:#333,color:#000
style F fill:#ef5350,stroke:#333,color:#000
style G fill:#4fc3f7,stroke:#333,color:#000
style H fill:#4fc3f7,stroke:#333,color:#000
style I fill:#ef5350,stroke:#333,color:#000
style J fill:#ef5350,stroke:#333,color:#000
style K fill:#81c784,stroke:#333,color:#000
style L fill:#81c784,stroke:#333,color:#000
style M fill:#81c784,stroke:#333,color:#000
style N fill:#ffd54f,stroke:#333,color:#000
style O fill:#ffd54f,stroke:#333,color:#000
style P fill:#ffd54f,stroke:#333,color:#000
style Q fill:#ffd54f,stroke:#333,color:#000
style R fill:#4fc3f7,stroke:#333,color:#000
graph TD
A["APP Processing"] -->|"amyloid-beta production"| B["Amyloid-beta Oligomers"]
B -->|"synaptic binding"| C["C1QA Upregulation"]
D["Cortical Layer Vulnerability"] -->|"spatial gradient"| C
E["Microglial Activation"] -->|"complement receptor expression"| F["C1q Complex Formation"]
C -->|"C1QA/C1QB/C1QC assembly"| F
F -->|"classical cascade initiation"| G["C3 Convertase Activation"]
G -->|"opsonization"| H["C3b Synaptic Tagging"]
H -->|"complement receptor binding"| I["CR3/CR4 Microglial Recognition"]
I -->|"phagocytic engulfment"| J["Synaptic Elimination"]
J -->|"aberrant pruning"| K["Synaptic Loss"]
K -->|"cortical layer dysfunction"| L["Cognitive Decline"]
M["C1q Inhibitors"] -->|"therapeutic blocking"| F
N["Microglial Modulators"] -->|"activation suppression"| E
O["Complement Regulators"] -->|"cascade interruption"| G
P["Neuroprotective Agents"] -->|"synaptic preservation"| J
classDef mechanism fill:#4fc3f7
classDef pathology fill:#ef5350
classDef therapy fill:#81c784
classDef outcome fill:#ffd54f
classDef genetics fill:#ce93d8
class A,B,F,G,H,I mechanism
class C,J,K,L pathology
class M,N,O,P therapy
class D,E genetics